|Bid||39.06 x 800|
|Ask||40.00 x 1300|
|Day's Range||37.96 - 39.48|
|52 Week Range||12.09 - 45.44|
|Beta (5Y Monthly)||2.29|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 28, 2021 - May 03, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||53.56|
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to seven new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update.
NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Insmed, Inc. (NASDAQ:INSM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 8:30 AM Eastern Time.